Speaking Out About the Future of Skin Cancer Treatment

September 3, 2020
Kristie L. Kahl
Kristie L. Kahl

Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.

Advocacy Groups | <b>Skin Cancer Foundation</b>

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Jeremy Brauer, on behalf of the Skin Cancer Foundation, about current treatment strategies and the future of the disease.

The treatment landscape looks bright for patients with skin cancer, especially with the medicine, technology and innovation going on in the space, according to Dr. Jeremy Brauer.

In this week’s episode, CURE® spoke to Brauer, a spokesperson for the Skin Cancer Foundation, about the current treatment strategies in skin cancer, and how immunotherapy and targeted agents have been a “game-changer” for those with advanced disease.

“Immunotherapy and targeted therapies, more of these are going to be made available to individuals with metastatic melanoma as well as advanced squamous cell carcinoma,” he said, adding that patients should be sure to become educated about their disease and treatment options.

“Knowledge is power. A great resource is your board-certified dermatologist, and also the resources available on reputable web sites like the Skin Cancer Foundation and all of the literature they have available. Within dermatology, there is the American Academy of Dermatology and other societies that are great resources. I do believe it begins with education.”